Patents Terms Extended Under 35 U.S.C. 156 Patent term extension certificates under 35 U.S.C. 156 extending the terms of the following patents were issued on December 15, 1994. U.S. Patent No. 3,929,971; Granted December 30, 1975, to Della M. Roy; Owner of Record: Research Corp. Technologies; Title: POROUS BIOMATERIALS AND METHOD OF MAKING SAME; Classification: 423/308; Product Trade Name: PRO OSTEON Implant 500 Coralline Hydroxyapatite Bone Void Filler; Term Extended: two years from the original expiration date of the patent. U.S. Patent No. 3,975,512; Granted August 17, 1976, to David M. Long, Jr.; Owner of Record: Board of Trustees of the University of Illinois; Title: NON-TOXIC BROMINATED PERFLUOROCARBONS RADIOPAQUE AGENTS; Classification: 424/5; Product Trade Name: Imagent GI; Term Extended: two years from the original expiration date of the patent. U.S. Patent No. 4,267,179; Granted May 12, 1981, to Jan Heeres, et. al.; Owner of Record: Janssen Pharmaceutica N.V.; Title: HETEROCYCLIC DERIVATIVES OF (4-PHENYLPIPERAZIN-1-YL-ARYLOXYMETHYL-1,3-DIOXOLAN-2-YL) METHYL-1H-IMIDAZOLES AND 1H-1,2,4-TRIAZOLES; Classification: 514/252; Product Trade Name: Sporanox; Term Extended: two years from the original expiration date of the patent. U.S. Patent No. 4,278,789; Granted July 14, 1981, to Robert D. Birkenmeyer; Owner of Record: The Upjohn Company; Title: LINCOMYCIN COMPOUNDS; Classification: 536/16.3; Product Trade Name: Pirsue Aqueous Gel; Term Extended: three years from the original expiration date of the patent. U.S. Patent No. 4,755,534; Granted July 5, 1988, to Anton Stuetz; Owner of Record: Sandoz Pharmaceuticals Corporation; Title: PROPENYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS; Classification: 514/655; Product Trade Name: Lamisil Cream; Term Extended: 543 days from the original expiration date of the patent.